Published Online: March 26, 2007 (doi:10.1001 /jama.297.15.jpc70004).
Author Contributions: Dr Tardif had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Tardif, Gregoire, L’Allier, Basser, Guertin.
Acquisition of data: Tardif, Gregoire, L’Allier, Ibrahim, Lesperance, Heinonen, Berry, Lavoie, Rodes-Cabau.
Analysis and interpretation of data: Tardif, Gregoire, L’Allier, Ibrahim, Lesperance, Kouz, Berry, Guertin, Rodes-Cabau.
Drafting of the manuscript: Tardif, Gregoire, Ibrahim, Heinonen.
Critical revision of the manuscript for important intellectual content: Tardif, Gregoire, L’Allier, Ibrahim, Lesperance, Kouz, Berry, Basser, Lavoie, Guertin, Rodes-Cabau.
Statistical analysis: L’Allier, Guertin.
Obtained funding: Tardif, Basser.
Administrative, technical, or material support: Tardif, Ibrahim, Lesperance, Heinonen, Berry, Basser, Rodes-Cabau.
Study supervision: Tardif, L’Allier, Ibrahim, Kouz, Lavoie, Rodes-Cabau.
Financial Disclosures: Dr Tardif holds the Pfizer and Canadian Institutes of Health Research chair in atherosclerosis. Dr Tardif reports that he has also received consultancy fees from Pfizer and AstraZeneca. Dr Basser is an employee of the sponsor and has equity ownership and stock options in CSL. No other authors reported financial disclosures.
Safety Review Committee: E. P. Brass (chair), B. O’Neill, and P. Watkins.
ERASE Investigators: D. G. Almond, S. L. Amyot, T. Anderson, J. Arnold, F. Azzari, F. Badir, G. Barbeau, A. Barolet, Y. Bastien, C. Berry, O. Bertrand, H. Beydoun, M. H. Blain, R. Bonan, F. Charbonneau, A. Chase, P. Chevalier, Y. Choquet, M.S. Clément, E. Cohen, C. Constance, J. Crépeau, J. Curtis, M. Curtis, P. Daly, R. de la Rochelière, P. DeGuise, A. Della Siega, J. P. Déry, A. Diaz, A. Dick, J. Diodati, S. Doucet, M. Doucet, J. Ducas, M. Dussureault, V. Dzavick, S. Fort, E. Fretz, R. Gagnon, R. Gallo, L. Gani, J. J. Gauthier, O. Gleeton, C. Glover, F. Gobeil, D. Goodhart, G. Gosselin, J. J. Graham, J. Grégoire, D. Hamel, J. Hansen, D. Hilton, S. Hodge, E. Horlick, F. Hussain, R. Ibrahim, D. Ing, J. Jaffer, M. Joyal, R. Kanaki, T. Kashour, P. Keller, C. Kells, B. J. Kidwai, R. Kinloch, P. Klinke, M. Knudtson, S. Kouz, J. Krahn, M. Labinaz, P. L'Allier, E. Larose, M. A. Lavoie, G. Leclerc, M. Lemay, M. Love, M. Madan, J. F. Marquis, G. Martin, S. McNicoll, R. Mildenberger, A. Miller, M. Montigny, T. Mouhieddin, S. Z. Naqvi, C. M. Nguyen, N. H. Nguyen, A. Nigam, S. Noble, B. Noel, E. O'Brien, R. Osman, D. Ouimet, H. Ouimet, C. B. Overgaard, D. Palisaitis, J. Pang, Y. Pesant, R. C. Philipp, J. Pouliot, M. Prabhakar, G. Proulx, K. A. Quraishi, P. Rabbath, F. Racette, S. Radhakrishnan, M. Ramma, F. Reeves, S. Rinfret, A. Rivard, J. Rodes, J. Ross, L. Roy, L. Schwartz, P. Seidelin, F. Spence, K. Sridhar, J. F. Tanguay, J. C. Tardif, P. Teefy, P. Tessier, P. Therriault, D. Tien-Wei Ko, L. Title, R. Towney, G. Turcotte, R. Vijayaraghavan, H. Von, H. C. Wijeysundera, W. Williams, M. Williams, and D. Williamson.
Independent Statistical Analysis: All statistical analyses were performed by biostatisticians at the Montreal Heart Institute Coordinating Center by Marie-Claude Guertin, PhD, Mariève Cossette, MSc, and Annick Fortier, MSc.
Funding/Support: Funding for this study was provided by CSL Ltd, Parkville, Victoria, Australia.
Role of the Sponsor: Investigators at the Montreal Heart Institute were responsible for the design of the study in collaboration with the sponsor (CSL). The sponsor was not involved in the conduct of the study (other than for providing study medication), collection, management, analysis, and interpretation of the data. The sponsor was not involved in the preparation or final approval of the manuscript but had the opportunity to review the article before submission.